BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28164066)

  • 21. Denosumab treatment for progressive skull base giant cell tumor of bone in a 14 year old female - a case report and literature review.
    Bardakhchyan S; Kager L; Danielyan S; Avagyan A; Karamyan N; Vardevanyan H; Mkhitaryan S; Papyan R; Zohrabyan D; Safaryan L; Sargsyan L; Harutyunyan L; Hakobyan L; Iskanyan S; Tamamyan G
    Ital J Pediatr; 2017 Mar; 43(1):32. PubMed ID: 28356124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and pathological results of denosumab treatment for giant cell tumors of bone: Prospective study of 14 cases.
    Deveci MA; Paydaş S; Gönlüşen G; Özkan C; Biçer ÖS; Tekin M
    Acta Orthop Traumatol Turc; 2017 Jan; 51(1):1-6. PubMed ID: 27784623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ZNF687 mutations are frequently found in pagetic patients from South Italy: implication in the pathogenesis of Paget's disease of bone.
    Divisato G; Scotto di Carlo F; Petrillo N; Esposito T; Gianfrancesco F
    Clin Genet; 2018 Jun; 93(6):1240-1244. PubMed ID: 29493781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteosarcoma in Paget's disease of bone.
    Hansen MF; Seton M; Merchant A
    J Bone Miner Res; 2006 Dec; 21 Suppl 2():P58-63. PubMed ID: 17229010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response of Aneurysmal Bone Cyst to Denosumab.
    Skubitz KM; Peltola JC; Santos ER; Cheng EY
    Spine (Phila Pa 1976); 2015 Nov; 40(22):E1201-4. PubMed ID: 26730528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
    Wojcik J; Rosenberg AE; Bredella MA; Choy E; Hornicek FJ; Nielsen GP; Deshpande V
    Am J Surg Pathol; 2016 Jan; 40(1):72-80. PubMed ID: 26414220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of RANK-ligand antibody (denosumab) treatment on bone turnover markers in a girl with juvenile Paget's disease.
    Grasemann C; Schündeln MM; Hövel M; Schweiger B; Bergmann C; Herrmann R; Wieczorek D; Zabel B; Wieland R; Hauffa BP
    J Clin Endocrinol Metab; 2013 Aug; 98(8):3121-6. PubMed ID: 23788687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The distinct clinical features of giant cell tumor of bone in pagetic and non-pagetic patients are associated with genetic, biochemical and histological differences.
    Divisato G; Scotto di Carlo F; Pazzaglia L; Rizzo R; Coviello DA; Benassi MS; Picci P; Esposito T; Gianfrancesco F
    Oncotarget; 2017 Sep; 8(38):63121-63131. PubMed ID: 28968976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paget's disease of bone and megaloblastic anemia in a 72-year-old patient: A case report and systematic literature review.
    Oprea VD; Bojincă VC; Bălănescu AR; Tatu AL; Bojincă M; Romila A
    Exp Ther Med; 2022 Apr; 23(4):269. PubMed ID: 35251335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risks and benefits of combining denosumab and surgery in giant cell tumor of bone-a case series.
    Müller DA; Beltrami G; Scoccianti G; Campanacci DA; Franchi A; Capanna R
    World J Surg Oncol; 2016 Nov; 14(1):281. PubMed ID: 27809843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paget's disease of bone: evidence for complex pathogenetic interactions.
    Chung PY; Van Hul W
    Semin Arthritis Rheum; 2012 Apr; 41(5):619-41. PubMed ID: 21959292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Unusual Case of Giant Cell Tumor of First Metatarsal: A Rare Case Report and Review of Literature.
    Prashant K; Bhattacharyya TD; Frank H; Ram P
    J Orthop Case Rep; 2016; 6(5):3-6. PubMed ID: 28507956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paget's disease of bone: Report of 11 cases.
    Miao XY; Wang XL; Lyu ZH; Ba JM; Pei Y; Dou JT; Gu WJ; Du J; Guo QH; Chen K; Mu YM
    World J Clin Cases; 2021 May; 9(14):3478-3486. PubMed ID: 34002161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Giant cell tumor: rapid recurrence after cessation of long-term denosumab therapy.
    Matcuk GR; Patel DB; Schein AJ; White EA; Menendez LR
    Skeletal Radiol; 2015 Jul; 44(7):1027-31. PubMed ID: 25712768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the role of RANK and OPG genes in Paget's disease of bone.
    Wuyts W; Van Wesenbeeck L; Morales-Piga A; Ralston S; Hocking L; Vanhoenacker F; Westhovens R; Verbruggen L; Anderson D; Hughes A; Van Hul W
    Bone; 2001 Jan; 28(1):104-7. PubMed ID: 11165949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guidelines for diagnosis and management of Paget's disease of bone in Japan.
    Takata S; Hashimoto J; Nakatsuka K; Yoshimura N; Yoh K; Ohno I; Yabe H; Abe S; Fukunaga M; Terada M; Zamma M; Ralston SH; Morii H; Yoshikawa H
    J Bone Miner Metab; 2006; 24(5):359-67. PubMed ID: 16937267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant Denosumab therapy following curettage and external fixator for a giant cell tumor of the distal radius presenting with a pathological fracture: A case report.
    Arulprashanth A; Faleel A; Palkumbura C; Jayarajah U; Sooriyarachchi R
    Int J Surg Case Rep; 2022 Jul; 96():107342. PubMed ID: 35785688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Giant cell tumour of bone in the denosumab era.
    van der Heijden L; Dijkstra PDS; Blay JY; Gelderblom H
    Eur J Cancer; 2017 May; 77():75-83. PubMed ID: 28365529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current options for the treatment of Paget's disease of the bone.
    Merlotti D; Gennari L; Martini G; Nuti R
    Open Access Rheumatol; 2009; 1():107-120. PubMed ID: 27789985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paget's Disease of Bone: An Entity Still Exists in India.
    Cherian KE; Kapoor N; Shetty S; Jebasingh FK; Asha HS; Hephzibah J; Prabhu AJ; Rajaratnam S; Thomas N; Paul TV
    Indian J Endocrinol Metab; 2018; 22(3):368-372. PubMed ID: 30090729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.